ArticleFrontiers in oncology2026
Ectopic craniopharyngioma recurrence: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We reported a case of ectopic recurrence of craniopharyngioma (CP) in the right temporal lobe and review the relevant literature to investigate its clinical features, pathogenesis, diagnosis and management. A 67-year-old male patient presented with blurred vision and was diagnosed with adamantinomatous CP(aCP) in the sellar region. Four years postoperatively, he developed implantation metastasis in the right temporal lobe along the surgical tract, and achieved a favorable prognosis after complete lesion resection via reoperation. Based on literature review, ectopic recurrence of CP is mainly associated with tumor cell dissemination and implantation along the surgical tract or cerebrospinal fluid spread. The adamantinomatous variant is the predominant pathological subtype.Standardized intraoperative tumor-free techniques and maximal resection of the primary lesion are the core preventive strategies, and long-term regular follow-up is mandatory for postoperative patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.